Recursion Pharmaceuticals, Inc. (RXRX)
4.76
-0.06
(-1.24%)
USD |
NASDAQ |
Dec 09, 16:00
4.75
-0.01
(-0.21%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap: 2.477B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 144.08B |
| Hims & Hers Health, Inc. | 9.074B |
| Eli Lilly & Co. | 878.59B |
| ACADIA Pharmaceuticals, Inc. | 4.549B |
| Amicus Therapeutics, Inc. | 3.025B |
Market Cap Related Metrics
| PS Ratio | 43.67 |
| PEG Ratio | -0.1424 |
| Price to Book Value | 2.366 |
| Price | 4.76 |
| Earnings Yield | -38.03% |
| PEGY Ratio | -0.1424 |